A new study shows that resveratrol, the antioxidant found in red wine, kills cancer cells from the inside and improves the effectiveness of radiation and chemotherapy cancer treatments.

Researchers, led by Paul Okunieff, M.D., chief of Radiation Oncology at the James P. Wilmot Cancer Center at the University of Rochester Medical Center, showed that the natural antioxidant from grape skins and red wine crippled the function of pancreatic cancer cell's core energy source or mitochondria

Help for chronic dry eye could be as easy as eye drops. A Massachusetts researcher told AHN Media he thinks he has found an effective treatment for dry eye syndrome (DES).

M. Reza Dana, M.D., M.P.H., M.Sc., Director of Cornea and Refractive Surgery Services at the Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service and colleagues at Schepens Eye Research Institute conducted a study using topical eye drop applications to relieve symptoms of DES

German health officials reported Thursday almost 100 cases of allergic reactions to heparin, a blood-thinning drug that was linked to 19 American deaths, U.S. officials announced Thursday. The U.S. Food and Drug Administration (FDA) is now urging all U.S. suppliers of heparin to start using some sophisticated screening tests to make sure their products are free of a contaminants.

On Wednesday, the FDA announced that tests had found a heparin-like contaminant in heparin blood-thinning products made by Chinese supplier of Baxter International Baxter. However the German version of the drug is a different brand than the heparin supplied by Illinois-based Baxter Healthcare Corp., officials added

Chinese shipments of Baxter International blood-thinner heparin contained large amounts of a contaminant that might explain hundreds of serious side effects, the U.S. Food and Drug Administration (FDA) said Wednesday. The federal agency believes that the shipment may have been tampered with before it arrived at the drug company's U.S. processing and distribution centers.

The government says that the contaminants used in blood-thinning drugs are under investigation but it could be a foreign substance that is similar in chemical make-up to heparin

GlaxoSmithKline PLC announced Friday that it will suspend development of its malaria drug Dacart and is recalling another drug, Lapdap, after it discovered the two drugs can lead to anemia.

Tests conducted by GSK and partner Medicines for Malaria Venture reveal both drugs lowered hemoglobin concentration in patients with hereditary enzyme deficiency disorders, which affects 10 to 25 percent of the sub-Saharan population in Africa